IMA Q3 2021 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$69M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+32.4% YoY

Gross Profit

-$10M-257.0% margin

Operating Income

-$15M-387.7% margin

Net Income

-$15M-387.5% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

+5.6%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$262M

Total Liabilities

$58M

Stockholders' Equity

$203M

Cash & Equivalents

$246M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$3M	+32.4%
Gross Profit	-$10M	-$4M	-119.4%
Operating Income	-$15M	-$6M	-133.0%
Net Income	-$15M	-$6M	-133.3%